Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Porphyria
ADR ID BADD_A03510
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.08      Metabolic and nutritional disorders congenital
03.08.01      Inborn errors of porphyrin metabolism
03.08.01.001      Porphyria
14      Metabolism and nutrition disorders
14.14      Inborn errors of metabolism
14.14.01      Inborn errors of porphyrin metabolism
14.14.01.001      Porphyria
Description A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. [MeSH]
MedDRA Code 10036181
MeSH ID D011164
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Porphyria | Porphyria NOS | Porphyria type syndrome | Porphyria aggravated | Porphyrias | Porphyrin Disorder | Disorder, Porphyrin | Disorders, Porphyrin | Porphyrin Disorders
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Delta-aminolevulinic acid dehydrataseP13716T20514
Delta-aminolevulinic acid dehydrataseQ5TJH2Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01937Rifapentine--
The 2th Page    First    Pre   2    Total 2 Pages